Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
HighPeak Energy
HPK
$903M
| $178K | ﹤0.01% |
11,300
-23,200
| -67% | -$344K |
|
|
OCFT
3252
DELISTED
OneConnect Financial Technology
OCFT
| $178K | ﹤0.01% |
79,960
| – | – |
|
3253
Cocrystal Pharma
COCP
$11.3M
| $176K | ﹤0.01% |
126,028
+900
| +0.7% | +$1.4K |
|
3254
Gain Therapeutics
GANX
$71.7M
| $176K | ﹤0.01% |
46,700
+3,900
| +9% | +$16.2K |
|
3255
Denison Mines
DNN
$2.54B
| $175K | ﹤0.01% |
89,400
-622,913
| -87% | -$1.18M |
|
|
HSAI
3256
Hesai Group
HSAI
$2.66B
| $175K | ﹤0.01% |
+34,500
| New | +$186K |
|
3257
PEDEVCO
PED
$144M
| $175K | ﹤0.01% |
10,925
-3,530
| -24% | -$51.7K |
|
|
UBX
3258
DELISTED
Unity Biotechnology
UBX
| $175K | ﹤0.01% |
106,941
+68,770
| +180% | +$119K |
|
|
ARIS
3259
Aris Mining
ARIS
$2.76B
| $174K | ﹤0.01% |
48,534
+14,900
| +44% | +$46.2K |
|
3260
ClearPoint Neuro
CLPT
$448M
| $174K | ﹤0.01% |
+25,612
| New | +$179K |
|
3261
Imunon
IMNN
$6.68M
| $174K | ﹤0.01% |
8,112
+1,050
| +15% | +$9.99K |
|
3262
Palladyne AI
PDYN
$247M
| $173K | ﹤0.01% |
95,778
-31,300
| -25% | -$31.9K |
|
3263
One Stop Systems
OSS
$303M
| $172K | ﹤0.01% |
52,900
+9,700
| +22% | +$26.5K |
|
3264
Maris-Tech
MTEK
$11.4M
| $171K | ﹤0.01% |
113,600
+98,243
| +640% | +$122K |
|
3265
Skillsoft
SKIL
$63.7M
| $171K | ﹤0.01% |
19,009
+5,500
| +41% | +$69.6K |
|
3266
BGSF Inc
BGSF
$59.5M
| $170K | ﹤0.01% |
16,300
-7,300
| -31% | -$72.6K |
|
|
ITRM
3267
DELISTED
Iterum Therapeutics
ITRM
| $170K | ﹤0.01% |
110,326
+60,404
| +121% | +$98.2K |
|
3268
Adaptive Biotechnologies
ADPT
$3.59B
| $169K | ﹤0.01% |
+52,583
| New | +$203K |
|
3269
ING
ING
$99.8B
| $169K | ﹤0.01% |
+10,275
| New | +$147K |
|
3270
Rafael Holdings
RFL
$101M
| $168K | ﹤0.01% |
99,176
-5,517
| -5% | -$9.65K |
|
3271
Bausch Health
BHC
$2.58B
| $165K | ﹤0.01% |
15,600
-249,689
| -94% | -$2.18M |
|
|
ICD
3272
DELISTED
Independence Contract Drilling, Inc.
ICD
| $164K | ﹤0.01% |
88,010
+15,210
| +21% | +$29.8K |
|
3273
Relmada Therapeutics
RLMD
$557M
| $163K | ﹤0.01% |
35,008
-111,881
| -76% | -$539K |
|
|
FAZ
3274
DELISTED
Direxion Daily Financial Bear 3x ETF
FAZ
| $161K | ﹤0.01% |
+1,640
| New | +$198K |
|
3275
IZEA Worldwide
IZEA
$60.6M
| $161K | ﹤0.01% |
69,703
+10,800
| +18% | +$22K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.